BioLineRx to Report First Quarter 2026 Results on May 27, 2026

Go back to BioLineRx to Report First Quarter 2026 Results on May 27, 2026
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.79 +0.15 (5.68%)
Previous Close $2.64    52 Week High $1.63 
Open $2.67    52 Week Low $0.71 
Day High $2.83    P/E N/A 
Day Low $2.67    EPS $0.00 
Volume 7,041       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.79 +0.15 (5.68%)
Previous Close $2.64    52 Week High $1.63 
Open $2.67    52 Week Low $0.71 
Day High $2.83    P/E N/A 
Day Low $2.67    EPS $0.00 
Volume 7,041